• Source: Rosmantuzumab

Rosmantuzumab (INN; development code OMP-131R10) is a humanized monoclonal antibody designed for the treatment of cancer.
This drug was developed by OncoMed Pharmaceuticals.




References

Kata Kunci Pencarian:

• Rosmantuzumab
• List of therapeutic monoclonal antibodies
• Minretumomab
• Naptumomab estafenatox
• Indium (111In) altumomab pentetate